Clinical Study
Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
Figure 3
Changes in fecal calprotectin concentration in prospective study. .